Cholinergic AntagonistsScopolamine HydrobromideMuscarinic AntagonistsParasympatholyticsAtropineParasympathomimeticsMecamylamineCholinergic AgonistsQuinuclidinyl BenzilateReceptors, CholinergicTrihexyphenidylCarbacholBenzilatesReceptors, MuscarinicAcetylcholineBiperidenScopolamine DerivativesOrphenadrineDose-Response Relationship, DrugIpratropiumAction PotentialsNortropanesPropanthelineGlycopyrrolateUrinary Bladder, OveractiveAnticholinergic SyndromeBronchodilator AgentsButylscopolammonium BromideAtropine DerivativesMandelic AcidsSalivationDisopyramideProcyclidineHistamine H1 AntagonistsUrinary Incontinence, UrgeHistamine AntagonistsAmitriptylineHormone AntagonistsNocturnal EnuresisPhysostigmineBasal Ganglia DiseasesNeurologic ManifestationsButylaminesDicyclomineDopamine AntagonistsAntipsychotic AgentsDeliriumDibenzazepinesExcitatory Amino Acid AntagonistsNeurokinin-1 Receptor AntagonistsAdministration, InhalationPiperidinesPulmonary Disease, Chronic ObstructiveDiphenoxylateSafety-Based Drug WithdrawalsQuinuclidinesNarcotic AntagonistsPhenylpropanolamineHistamine H2 AntagonistsAtropa belladonnaInterleukin 1 Receptor Antagonist ProteinPolypharmacyBelladonna AlkaloidsCholinesterase InhibitorsDouble-Blind MethodUrodynamicsPyrrolidinesAdrenergic beta-AgonistsTropanesUrinary IncontinenceCyclopentolateMianserinGABA AntagonistsEducation, Pharmacy, ContinuingRadioligand AssayUrinary RetentionNeuromuscular AgentsPurinergic P1 Receptor AntagonistsMaprotilineBotulinum Toxins, Type AGuinea PigsProtriptylineGlycolatesRats, Sprague-DawleyDrug Therapy, CombinationUrinary Bladder, NeurogenicCarbofuranCognition DisordersNicotinic AntagonistsAdenosine A2 Receptor AntagonistsReceptor, Muscarinic M3Akathisia, Drug-InducedClergyAdrenergic alpha-1 Receptor AntagonistsDrug SubstitutionPurinergic P2 Receptor AntagonistsCresolsDatura stramoniumCatholicismPirenzepine